Private Label Isn't a Pricing Problem — It's a Capital-Allocation Problem

Almost every piece written about private label this year frames it as a marketing problem. Compete on storytelling. Invest in premium packaging. Own your category. That advice isn't wrong, but it's answering the wrong question. From the finance seat, the rise of store brands isn't a branding event — it's a signal that the return on a dollar spent defending shelf space is falling, and that you need to decide, deliberately, where that dollar goes instead.

That's a capital-allocation decision. And most founders are making it by reflex — spending to defend everything — at exactly the moment the math stopped supporting that.

What actually changed

The headline numbers are real and they matter. By the first half of 2026, store brands reached a record 23.8% of grocery units¹, and private-label sales topped $330 billion a year — roughly a quarter of every food-and-beverage dollar². National-brand unit sales slipped while private label kept gaining¹. None of that is a blip; the reporting has stopped calling it a trade-down cycle and started calling it structural³.

Here's the part that changes the strategy. The old defense was quality: consumers reached for the national brand because the store brand was visibly worse. That gap has closed for a lot of categories. “Solid quality at a fair price” is now table stakes, not a moat. Worse, the retailer holds cards you can't match — first-party purchase data, control of the shelf and the planogram, a retail-media network you have to pay into to reach the shopper standing in their store, and a closed loop that tells them exactly where your price is soft.

So the ground under “fight for the shelf” has shifted twice: the thing you were defending (quality advantage) is weaker, and the cost of defending it (trade spend, slotting, promotion, retail media) is higher and increasingly set by your competitor. That is the definition of a compressing return.

The framework: defend, differentiate, or concede

You don't answer this at the brand level. You answer it SKU by SKU, or category by category, because the right call is different for each. Run your portfolio through three buckets.

1. Defend — where you have an advantage private label can't copy

Keep spending where you hold a structural edge: a proprietary formulation, a functional benefit (shelf-life, a health claim, a performance attribute) that a contract manufacturer can't replicate on a store-brand budget, a genuinely differentiated supply chain, or a brand that consumers actively seek by name rather than settle for. In these categories the trade spend still earns its return, because the shopper won't accept the substitute. Defend them with conviction and fund the innovation that keeps the gap open.

2. Differentiate — where you can't win on price, so you move up

This is the middle, and it's where most of the value — and most of the mistakes — live. If the store brand has matched you on quality and undercut you on price, matching its price is a losing trade; you're just funding your own margin compression. The move is up, not down: a real product difference that justifies a premium. But be honest about “real.” The market has gone K-shaped, and so-called barbell pricing⁴ — win the value shopper and the premium shopper, abandon the middle — is far easier to say than to execute. A premium tier only holds if the difference is something the shopper can taste, feel, or measure. Premium packaging around a parity product is a cost, not a strategy.

3. Concede — where the gap has closed and the dollar is better spent elsewhere

The hardest one for a founder to say out loud: some SKUs are commodities now, the store brand is as good, and you will not win them back by spending more. In those categories, stop pouring trade dollars into a defense that no longer returns. Harvest the margin while you have distribution, don't reinvest in the fight, and — this is the whole point — redeploy the freed-up capital into buckets one and two. Conceding a losing category isn't surrender. It's refusing to set money on fire.

The margin math you have to run first

The framework is only as good as the numbers underneath it, so build the picture before you make the calls. Two realities tend to get missed.

First, the gross-margin structure varies enormously by category, and it dictates how much room you have to maneuver. A food or beverage line often runs somewhere around a 40% gross margin; a beauty or personal-care line can run 60–70%⁵. The category with the fatter margin can absorb a premium-tier investment or a promotional defense that the thin-margin category simply can't. Don't apply one playbook across a portfolio with two very different cost structures — the “defend” bucket is bigger where the margin can fund the defense.

Second, making private label for the retailer is not the free hedge it looks like. When volume softens, the tempting move is to fill the plant by co-manufacturing the store brand. Sometimes that's the right capacity decision. But private-label supply is a low-margin, deduction-heavy business — chargebacks and retail deductions quietly eat the spread⁶ — and you're now manufacturing the very volume that competes with your own brand on the next shelf over. Run it as a clear-eyed capacity-utilization decision with the deductions modeled in, not as a reflexive hedge. This is the same make-vs-buy logic that governs any copacking call; the counterparty just happens to be your competitor.

How to actually run it

Put your SKU list in a spreadsheet and, for each line, force an answer to four questions:

• Advantage: do I have a structural edge here a store brand can't replicate — yes or no? Be strict. “Our shopper is loyal” is not an edge if the data says they're substituting.
• Margin room: what's the gross margin on this line, and can it fund either a defense or a move up-market?
• Trend: is this SKU gaining or losing share to private label over the last four quarters, and is the trade spend behind it rising or flat?
• Verdict: defend, differentiate, or concede — and if concede, where does the freed capital go?

Do that honestly across the portfolio and the strategy writes itself. You'll usually find a handful of SKUs worth defending hard, a cluster worth pushing up-market, and a tail you've been subsidizing out of habit. The tail is your funding source for everything else.